Answers are grounded in this paper and cite their sources.
We should stop and think about the risks of resistance, and ways of minimising them, before increasing access to antiretroviral therapy in Africa
No takes yet. Share an insight, caveat, or question.
Warren Stevens (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: